Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000171943 | SCV000050941 | uncertain significance | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV001297172 | SCV001486158 | uncertain significance | Dilated cardiomyopathy 1J | 2023-05-22 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 191659). This variant has not been reported in the literature in individuals affected with EYA4-related conditions. This variant is present in population databases (rs201644472, gnomAD 0.0009%). This sequence change replaces threonine, which is neutral and polar, with arginine, which is basic and polar, at codon 78 of the EYA4 protein (p.Thr78Arg). |
Fulgent Genetics, |
RCV002492715 | SCV002776430 | uncertain significance | Dilated cardiomyopathy 1J; Autosomal dominant nonsyndromic hearing loss 10 | 2021-11-05 | criteria provided, single submitter | clinical testing |